About Contact Us Careers

Hemorrhoid Drugs Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3057
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Hemorrhoid Drugs Landscape

Aytu Consumer Health, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Takeda Consumer Healthcare Company (Arinamin Pharmaceutical Co., Ltd.)
Taro Pharmaceutical Industries Ltd.
AstraZeneca plc
The Himalaya Drug Company
Panacea Biotec Ltd.
Abbott Laboratories
Sanofi-aventis Groupe
Pfizer Inc.
Purdue Pharma L.P.

Browse Key Market Insights with Data Illustration:

Hemorrhoid Drugs Market Size & Share, Growth Report 2037

In the News

Author Credits: Radhika Pawar

Report ID: 3057
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Hemorrhoid Drugs Market size is likely to expand at significant growth rate during the forecast period i.e., between 2025-2037.

Growing prevalence of piles or hemorrhoids on the back of poor diet, lifestyle diseases and obesity, will propel the market growth.

Europe industry is likely to account for largest revenue share by 2037, on the back of high geriatric population, coupled with availability of advanced treatment options, better reimbursement policies and fast commercialization of novel products.

The major players in the market are Taro Pharmaceutical Industries Ltd., AstraZeneca, The Himalaya Drug Company, Panacea Biotec Ltd., Abbott Healthcare Private Limited, Sanofi-aventis Groupe, Pfizer Inc., Purdue Pharma L.P and others.

Inquiry Before Buying Request Free Sample